{"prompt": "['Co', 'Cochlear', 'The benefit in health-related quality of life (HRQoL) measured by the difference in', 'scores with HUI when using the at 3 and 6-months post-surgery compared to the pre-', 'operative hearing situation.', 'Surgical information:', 'Soft tissue thickness', 'Surgery time', 'Bone polishing/removal at the actuator site', 'BI300 Implant length', 'Location of BI300 Implant', 'Type of anaesthesia', 'Soft tissue reduction', 'Surgical incision type', 'Length of the surgical incision', 'Placement of the coil', 'Location of the surgical incision in relation to the actuator', 'Usage information:', 'Magnet choice', 'Sound Processor retention', 'Sound Processor wearing comfort', 'Use of SoftWear pad', 'Daily use', 'Daily streaming', 'Battery lifetime', 'The difference in hearing performance between the Investigational device and to a', 'Baha 5 Power Sound Processor on a Baha Softband (preoperative) assessed at', 'fitting, 3- and 6-months post-surgery as:', 'The difference in Thresholds audiometry, free-field [PTA4, mean of 0.5, 1, 2', 'and 4 kHz].', 'The difference in Thresholds audiometry, free-field [0.25, 0.5, 0.75, 1.0, 1.5,', '2.0, 3.0, 4.0, 6.0 and 8.0 kHz].', 'The difference in Adaptive speech in noise [signal-to-noise ratio, 50% speech', 'understanding].', 'The difference in Speech in quiet [% correctly repeated words at 50dB, 65dB', 'and 80dB SPL].', 'BC Direct [0.25, 0.5, 0.75, 1.0, 1.5, 2.0, 3.0, 4.0 and 6.0 kHz] will be performed using', 'a Baha Softband (preoperatively) at screening/baseline and using the Investigational', 'device at fitting, 3- and 6-months post-surgery.', 'Template 1278855 Version 1.0', '54 of 75']['Co', 'Cochlear', '9.2.3', 'Tertiary Outcome measures', 'The difference in hearing performance at fitting- 3- and 6 months post-surgery when', 'using the Investigational device compared to a preoperative hearing aid (if used by', 'the patient) assessed as:', 'The difference in Adaptive speech in noise [signal-to-noise ratio, 50% speech', 'understanding].', 'Feedback measurements to be collected the Investigational device.', '9.2.4', 'Exploratory Outcome measures.', 'There are no exploratory Outcome measures.', '9.3 Hypotheses', 'The hierarchical testing procedure below is introduced to guarantee that the probability of Type', 'I error is < 2.5% for allconfirmativestatements. Theorder of the hierarchical testing procedure', 'will be:', '1. PTA 4 pre-operative unaided vs. 3 months post-surgery (Primary efficacy analysis)', '2. Adaptive speech recognition in noise (50% performance), signal to noise ratio (SNR)', 'pre-operative unaided vs. 3 months post-surgery', '3. Speech in quiet at 65dB SPL pre-operative unaided VS. 3 months post-surgery', '4. APHAB Global pre-operative unaided VS. 2 months post fitting aided', '5. Hearing attribute (HUI) pre-operative situation VS. 3 months post-surgery', '6. Mean of the 12 items (Total score) in the SSQ pre-op unaided VS. 3 months post-', 'surgery', 'If the first analysis is significant the probability mass 0.025 will go to the second analysis. If the', 'second analysis is also significant the probability mass 0.025 will go to the third analysis and', 'so on. When the first non-significant analysis is reached this and all analyses thereafter will be', 'non-confirmative while the previous analyses will be confirmative. If the first analysis is non-', 'significant no analysis will be confirmative. All testing will be Alpha level of 0.025 and one sided', 'test will be used and the analysis will be performed on the ITT.', '9.3.1', 'Primary Hypothesis', 'Group mean free-field PTA4 (average of 500, 1000, 2000, and 4000 Hz) with the', 'Investigational device at the 3-month postoperative interval will be improved over that', 'measured preoperatively in the unaided condition (baseline).', 'This endpoint is represented by the following hypotheses:', 'Ho:Mp-ao=0,', '-', 'Template 1278855 Version 1.0', '55 of 75']\n\n###\n\n", "completion": "END"}